A cross-sectional study on the factors influencing drug resistance in clinical Mycobacterium tuberculosis in Hulunbuir, Inner Mongolia

Introduction/Objective. This study aimed to improve the understanding of drug-resistant tuberculosis (TB) by conducting a retrospective analysis of clinical data from TB patients in Hulunbuir, Inner Mongolia, collected between 2015 and 2017. Methods. A retrospective analysis was performed on clinica...

Full description

Saved in:
Bibliographic Details
Main Authors: Guo Huijun, Yu Yanqin, Hao Jinqi, Zhang Lan, Hao Mingyuan
Format: Article
Language:English
Published: Serbian Medical Society 2025-01-01
Series:Srpski Arhiv za Celokupno Lekarstvo
Subjects:
Online Access:https://doiserbia.nb.rs/img/doi/0370-8179/2025/0370-81792500001G.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849773672420605952
author Guo Huijun
Yu Yanqin
Hao Jinqi
Zhang Lan
Hao Mingyuan
author_facet Guo Huijun
Yu Yanqin
Hao Jinqi
Zhang Lan
Hao Mingyuan
author_sort Guo Huijun
collection DOAJ
description Introduction/Objective. This study aimed to improve the understanding of drug-resistant tuberculosis (TB) by conducting a retrospective analysis of clinical data from TB patients in Hulunbuir, Inner Mongolia, collected between 2015 and 2017. Methods. A retrospective analysis was performed on clinical data from patients with TB. The data were used to determine monodrug resistance rankings for ethambutol, isoniazid, rifampicin (RIF), and streptomycin. Additionally, the study examined drug resistance rates for multidrug resistance (MDR) combinations, specifically isoniazid + RIF + streptomycin and isoniazid + RIF + ethambutol + streptomycin. A multivariate logistic regression analysis was conducted to assess risk factors for drug resistance, including sex, hospitalization status, age, and treatment history. Results. The findings revealed that both MDR combinations had resistance rates of 4.51%, the highest among the combinations analyzed. Ethambutol, isoniazid, and RIF showed the three highest monodrug resistance rates. Patients undergoing retreatment had higher rates of monodrug resistance, MDR, and polydrug resistance compared with those receiving initial treatment. The multivariate logistic regression analysis indicated that women had a lower risk of developing drug resistance than men, and hospitalized patients were found to be at lower risk than outpatients. Being 20–40 years old and undergoing retreatment were identified as significant risk factors for developing drug-resistant TB. Conclusion. In the Hulunbuir region of Inner Mongolia, there was a notable presence of drug resistance among patients with TB, with specific demographic and treatment history factors contributing to this resistance. These findings underscore the importance of considering these factors in developing targeted treatment strategies and public health policies to combat drug-resistant TB.
format Article
id doaj-art-5e25f24814e8436e8b5b61e0f397d0bb
institution DOAJ
issn 0370-8179
2406-0895
language English
publishDate 2025-01-01
publisher Serbian Medical Society
record_format Article
series Srpski Arhiv za Celokupno Lekarstvo
spelling doaj-art-5e25f24814e8436e8b5b61e0f397d0bb2025-08-20T03:01:58ZengSerbian Medical SocietySrpski Arhiv za Celokupno Lekarstvo0370-81792406-08952025-01-011531-2293410.2298/SARH240520001G0370-81792500001GA cross-sectional study on the factors influencing drug resistance in clinical Mycobacterium tuberculosis in Hulunbuir, Inner MongoliaGuo Huijun0Yu Yanqin1Hao Jinqi2Zhang Lan3Hao Mingyuan4School of Public Health, Baotou Medical College, Baotou, Inner Mongolia, ChinaSchool of Public Health, Baotou Medical College, Baotou, Inner Mongolia, ChinaSchool of Public Health, Baotou Medical College, Baotou, Inner Mongolia, ChinaSchool of Public Health, Baotou Medical College, Baotou, Inner Mongolia, ChinaThe Second People’s Hospital in Hulunbuir, Zaerdong, Inner Mongolia, ChinaIntroduction/Objective. This study aimed to improve the understanding of drug-resistant tuberculosis (TB) by conducting a retrospective analysis of clinical data from TB patients in Hulunbuir, Inner Mongolia, collected between 2015 and 2017. Methods. A retrospective analysis was performed on clinical data from patients with TB. The data were used to determine monodrug resistance rankings for ethambutol, isoniazid, rifampicin (RIF), and streptomycin. Additionally, the study examined drug resistance rates for multidrug resistance (MDR) combinations, specifically isoniazid + RIF + streptomycin and isoniazid + RIF + ethambutol + streptomycin. A multivariate logistic regression analysis was conducted to assess risk factors for drug resistance, including sex, hospitalization status, age, and treatment history. Results. The findings revealed that both MDR combinations had resistance rates of 4.51%, the highest among the combinations analyzed. Ethambutol, isoniazid, and RIF showed the three highest monodrug resistance rates. Patients undergoing retreatment had higher rates of monodrug resistance, MDR, and polydrug resistance compared with those receiving initial treatment. The multivariate logistic regression analysis indicated that women had a lower risk of developing drug resistance than men, and hospitalized patients were found to be at lower risk than outpatients. Being 20–40 years old and undergoing retreatment were identified as significant risk factors for developing drug-resistant TB. Conclusion. In the Hulunbuir region of Inner Mongolia, there was a notable presence of drug resistance among patients with TB, with specific demographic and treatment history factors contributing to this resistance. These findings underscore the importance of considering these factors in developing targeted treatment strategies and public health policies to combat drug-resistant TB.https://doiserbia.nb.rs/img/doi/0370-8179/2025/0370-81792500001G.pdfmycobacterium tuberculosisdrug resistanceinfluence factor
spellingShingle Guo Huijun
Yu Yanqin
Hao Jinqi
Zhang Lan
Hao Mingyuan
A cross-sectional study on the factors influencing drug resistance in clinical Mycobacterium tuberculosis in Hulunbuir, Inner Mongolia
Srpski Arhiv za Celokupno Lekarstvo
mycobacterium tuberculosis
drug resistance
influence factor
title A cross-sectional study on the factors influencing drug resistance in clinical Mycobacterium tuberculosis in Hulunbuir, Inner Mongolia
title_full A cross-sectional study on the factors influencing drug resistance in clinical Mycobacterium tuberculosis in Hulunbuir, Inner Mongolia
title_fullStr A cross-sectional study on the factors influencing drug resistance in clinical Mycobacterium tuberculosis in Hulunbuir, Inner Mongolia
title_full_unstemmed A cross-sectional study on the factors influencing drug resistance in clinical Mycobacterium tuberculosis in Hulunbuir, Inner Mongolia
title_short A cross-sectional study on the factors influencing drug resistance in clinical Mycobacterium tuberculosis in Hulunbuir, Inner Mongolia
title_sort cross sectional study on the factors influencing drug resistance in clinical mycobacterium tuberculosis in hulunbuir inner mongolia
topic mycobacterium tuberculosis
drug resistance
influence factor
url https://doiserbia.nb.rs/img/doi/0370-8179/2025/0370-81792500001G.pdf
work_keys_str_mv AT guohuijun acrosssectionalstudyonthefactorsinfluencingdrugresistanceinclinicalmycobacteriumtuberculosisinhulunbuirinnermongolia
AT yuyanqin acrosssectionalstudyonthefactorsinfluencingdrugresistanceinclinicalmycobacteriumtuberculosisinhulunbuirinnermongolia
AT haojinqi acrosssectionalstudyonthefactorsinfluencingdrugresistanceinclinicalmycobacteriumtuberculosisinhulunbuirinnermongolia
AT zhanglan acrosssectionalstudyonthefactorsinfluencingdrugresistanceinclinicalmycobacteriumtuberculosisinhulunbuirinnermongolia
AT haomingyuan acrosssectionalstudyonthefactorsinfluencingdrugresistanceinclinicalmycobacteriumtuberculosisinhulunbuirinnermongolia
AT guohuijun crosssectionalstudyonthefactorsinfluencingdrugresistanceinclinicalmycobacteriumtuberculosisinhulunbuirinnermongolia
AT yuyanqin crosssectionalstudyonthefactorsinfluencingdrugresistanceinclinicalmycobacteriumtuberculosisinhulunbuirinnermongolia
AT haojinqi crosssectionalstudyonthefactorsinfluencingdrugresistanceinclinicalmycobacteriumtuberculosisinhulunbuirinnermongolia
AT zhanglan crosssectionalstudyonthefactorsinfluencingdrugresistanceinclinicalmycobacteriumtuberculosisinhulunbuirinnermongolia
AT haomingyuan crosssectionalstudyonthefactorsinfluencingdrugresistanceinclinicalmycobacteriumtuberculosisinhulunbuirinnermongolia